Evidence map›Paper›PMID 37582490›Full record

ReviewAnnual review of medicine2024

Carbon Monoxide Poisoning: From Microbes to Therapeutics.

Matthew R Dent, Jason J Rose, Jesús Tejero, Mark T Gladwin

Open access · hybridAbstract readReview
In one paragraph

Review in Annual review of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cytochrome bFree radical biology & medicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CytochromebioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Engineering a highly selective, hemoprotein-based scavenger as a carbon monoxide poisoning antidote with no hypertensive effect.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Matthew R DentHeart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; email: mrd109@pitt.edu, jet68@pitt.edu.
Jason J RoseDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; email: jjrose@som.umaryland.edu, mgladwin@som.umaryland.edu.
Jesús TejeroHeart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; email: mrd109@pitt.edu, jet68@pitt.edu.
Mark T GladwinDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; email: jjrose@som.umaryland.edu, mgladwin@som.umaryland.edu.
University of Maryland, Baltimore · USUniversity of Pittsburgh · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 2011 to 2020
$26.1M
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
Translational Training Program in Pulmonary Biology and MedicineT32HL007563 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Koenigshoff · 1985 to 2026
$12.3M
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobinR01HL125886 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin, Jesus Tejero Bravo · 2015 to 2026
$7.9M
Translational Pulmonary Vascular BiologyT32HL110849 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sruti Shiva · 2012 to 2026
$5.0M
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoningR42ES031993 · NIEHS · GLOBIN SOLUTIONS, INC. · PI ROSE, JASON J, TEJERO BRAVO, JESUS · 2020 to 2022
$1.7M
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular DysfunctionK08HL136857 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSE, JASON J · 2018 to 2022
$970k
Optimization of a carbon monoxide (CO) sensing hemoprotein for applications as an antidote for CO poisoning and a biosensor for CO detection in living cellsK99HL168224 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DENT, MATTHEW RYAN · 2023 to 2024
$326k
Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide PoisoningF32HL132418 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSE, JASON J · 2016 to 2017
$97k
Development of a carbon monoxide scavenging hemoprotein as a novel antidotal therapy to treat inhaled CO poisoningF32HL162381 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DENT, MATTHEW RYAN · 2022 to 2022
$77k
NHLBI NIH HHS F32 HL132418NHLBI NIH HHS F32 HL162381NHLBI NIH HHS K08 HL136857NHLBI NIH HHS K99 HL168224NHLBI NIH HHS P01 HL103455NHLBI NIH HHS R01 HL098032NHLBI NIH HHS R01 HL125886NHLBI NIH HHS T32 HL007563NHLBI NIH HHS T32 HL110849NIEHS NIH HHS R42 ES031993
6 · The paper itself

Abstract

Carbon monoxide (CO) poisoning leads to 50,000-100,000 emergency room visits and 1,500-2,000 deaths each year in the United States alone. Even with treatment, survivors often suffer from long-term cardiac and neurocognitive deficits, highlighting a clear unmet medical need for novel therapeutic strategies that reduce morbidity and mortality associated with CO poisoning. This review examines the prevalence and impact of CO poisoning and pathophysiology in humans and highlights recent advances in therapeutic strategies that accelerate CO clearance and mitigate toxicity. We focus on recent developments of high-affinity molecules that take advantage of the uniquely strong interaction between CO and heme to selectively bind and sequester CO in preclinical models. These scavengers, which employ heme-binding scaffolds ranging from organic small molecules to hemoproteins derived from humans and potentially even microorganisms, show promise as field-deployable antidotes that may rapidly accelerate CO clearance and improve outcomes for survivors of acute CO poisoning.

Indexed as

Carbon Monoxide PoisoningHemeHumansUnited StatesHemeantidotescarbon monoxidecarbon monoxide poisoninghememitochondria

Identifiers

PMID37582490
PMCPMC11160397
OpenAlexW4385830419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.